Lead Product(s) : Brivudine
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 29, 2019
Lead Product(s) : Brivudine
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
